# Denise M. Wolf

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/denise-m-wolf/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,015 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 44 |
| i10-index | 73 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5005988887 |
| ORCID iD | https://orcid.org/0000-0002-3676-653X |
| Works | 269 |

## Researcher papers

- [The Immune Landscape of Cancer](https://scholariq.org/papers/the-immune-landscape-of-cancer/)
- [An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics](https://scholariq.org/papers/an-integrated-tcga-pan-cancer-clinical-data-resource-to-drive-high-quality/)
- [Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer](https://scholariq.org/papers/cell-of-origin-patterns-dominate-the-molecular-classification-of-10-000-tumors/)
- [Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas](https://scholariq.org/papers/genomic-and-molecular-landscape-of-dna-damage-repair-deficiency-across-the/)
- [A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments](https://scholariq.org/papers/a-natural-killer-dendritic-cell-axis-defines-checkpoint-therapy-responsive-tumor/)
- [The Immune Landscape of Cancer](https://scholariq.org/papers/the-immune-landscape-of-cancer-2/)
- [Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival](https://scholariq.org/papers/circulating-tumor-dna-in-neoadjuvant-treated-breast-cancer-reflects-response-and/)
- [Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial](https://scholariq.org/papers/durvalumab-with-olaparib-and-paclitaxel-for-high-risk-her2-negative-stage-ii-iii/)
- [Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis](https://scholariq.org/papers/circulating-tumor-cells-in-breast-cancer-patients-treated-by-neoadjuvant/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.